A First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at Cardiovascular Risk With Elevated CRP
A First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at Cardiovascular Risk With Elevated CRP
Active, not recruiting · NCT07119125 · Registry updated 2026-06-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at Cardiovascular Risk With Elevated CRP | Elevated CRP; Healthy Volunteers | Active, not recruiting | Phase 1 | 2026-06-04 | NCT07119125 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Monte Rosa Therapeutics, Inc | 3 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Clinical Pharmacology of Miami, LLC | Miami | United States | 2 |
| Endeavor Clinical Trials | San Antonio | United States | 17 |
| ICON Clinical Research | Lenexa | United States | 2 |
| QPS | Springfield | United States | 1 |